Assessing the Potential of Untargeted SWATH Mass Spectrometry-Based Metabolomics to Differentiate Closely Related Exposures in Observational Studies

Mass spectrometry (MS) is increasingly used in clinical studies to obtain molecular evidence of chemical exposures, such as tobacco smoke, alcohol, and drugs. This evidence can help verify clinical data retrieved through anamnesis or questionnaires and may provide insights into unreported exposures,...

Descripción completa

Detalles Bibliográficos
Autores principales: Klont, Frank, Sosnowski, Piotr, Kremer, Daan, Knobbe, Tim J., Bonner, Ron, Blokzijl, Hans, Weersma, Rinse K., Bakker, Stephan J. L., Investigators, TransplantLines, Hak, Eelko, Touw, Daan J., Hopfgartner, Gérard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611019/
https://www.ncbi.nlm.nih.gov/pubmed/36295843
http://dx.doi.org/10.3390/metabo12100942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611019/
https://www.ncbi.nlm.nih.gov/pubmed/36295843
http://dx.doi.org/10.3390/metabo12100942

Ejemplares similares